Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
GR Davies, M Chaplin, M De Vos… - Cochrane Database …, 2022 - cochranelibrary.com
Background The World Health Organization (WHO) End TB Strategy stresses universal
access to drug susceptibility testing (DST). DST determines whether Mycobacterium …
access to drug susceptibility testing (DST). DST determines whether Mycobacterium …
Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in …
Background There is a need for short and safe all-oral treatment of rifampicin-resistant
tuberculosis. We compared outcomes up to 24 months after treatment initiation for patients …
tuberculosis. We compared outcomes up to 24 months after treatment initiation for patients …
[HTML][HTML] All nonadherence is equal but is some more equal than others? Tuberculosis in the digital era
HR Stagg, M Flook, A Martinecz, K Kielmann… - ERJ Open …, 2020 - Eur Respiratory Soc
Adherence to treatment for tuberculosis (TB) has been a concern for many decades,
resulting in the World Health Organization's recommendation of the direct observation of …
resulting in the World Health Organization's recommendation of the direct observation of …
Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects
Background Drug-resistant tuberculosis (DR-TB) is the barrier for global TB elimination
efforts with a lower treatment success rate. Loss to follow-up (LTFU) in DR-TB is a serious …
efforts with a lower treatment success rate. Loss to follow-up (LTFU) in DR-TB is a serious …
Краткосрочные схемы лечения больных туберкулезом с множественной лекарственной устойчивостью. Современная ситуация и дальнейшие перспективы
АЕ Русских, ДМ Кутузова, ОВ Ловачева… - … и болезни легких, 2021 - tibl-journal.com
Аннотация В обзоре проанализировано 70 источников литературы. Представлены
актуальные данные о препаратах, сроках, показаниях к применению, эффективности и …
актуальные данные о препаратах, сроках, показаниях к применению, эффективности и …
Measuring and reporting treatment adherence: What can we learn by comparing two respiratory conditions?
Medication non‐adherence, defined as any deviation from the regimen recommended by
their healthcare provider, can increase morbidity, mortality and side effects, while reducing …
their healthcare provider, can increase morbidity, mortality and side effects, while reducing …
“Death is a better option than being treated like this”: a prevalence survey and qualitative study of depression among multi-drug resistant tuberculosis in-patients
Background Understanding of the relationship between multi-drug resistant tuberculosis and
mental health is limited. With growing prevalence of multi-drug resistant tuberculosis …
mental health is limited. With growing prevalence of multi-drug resistant tuberculosis …
Drug resistance profiles of Mycobacterium tuberculosis clinical isolates by genotype MTBDRplus line probe assay in Zambia: findings and implications
MH Kangongwe, W Mwanza, M Mwamba… - JAC-Antimicrobial …, 2024 - academic.oup.com
Background The emergence of drug resistance is a threat to global tuberculosis (TB)
elimination goals. This study investigated the drug resistance profiles of Mycobacterium …
elimination goals. This study investigated the drug resistance profiles of Mycobacterium …
Risk factors for poor engagement in drug-resistant TB care in South Africa: a systematic review
KC McNabb, A Bergman, JE Farley - Public Health Action, 2021 - ingentaconnect.com
BACKGROUND: Metrics of poor patient engagement, including missed appointments,
treatment interruption, sub-optimal medication adherence, and loss to follow-up, have been …
treatment interruption, sub-optimal medication adherence, and loss to follow-up, have been …
Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis
LP James, F Klaassen, S Sweeney, J Furin… - Plos …, 2024 - journals.plos.org
Background Emerging evidence suggests that shortened, simplified treatment regimens for
rifampicin-resistant tuberculosis (RR-TB) can achieve comparable end-of-treatment (EOT) …
rifampicin-resistant tuberculosis (RR-TB) can achieve comparable end-of-treatment (EOT) …